JPAN
Login Submit Article

A Comparative study of COVID-19 related internalized stigma, Anxiety and Depressive symptoms among COVID-19 Cases and Suspects in Nepal

Bigya Shah
Department of Psychiatry, Patan Academy of Health Sciences, School of Medicine, Patan Hospital, Nepal
Ananya Mahapatra
Consultant Psychiatrist, Cognis Mindcare, New Delhi, Nepal
Sunil Kumar Daha
General Physician, Ministry of Health, Oman
Uday Narayan Singh
Department of Emergency Medicine, Narayani Hospital, Birgunj, Nepal
Vilok Mishra
Department of Dermatology, Kanti Children’s Hospital, Nepal
Rajan Pande
Department of Internal Medicine, Bheri Hospital, Nepalgunj, Nepal
Madan Ratna Neupane
Medical Director, Ratna Prasad Neupane Foundation, Kathmandu, Nepal
Anita Banjade
Department of Pediatrics, Meritus Medical Center, Maryland, USA
Chandra Bhal Khatik
Medical Officer, Nepalgunj Medical College, Kathmandu, Nepal
Tej Bahadur K.C.
Department of Internal Medicine, Maharajgunj Medical Campus, Tribhuvan University, Nepal
Rajesh Kumar Mandal
Department of Internal Medicine, Bheri Hospital, Nepalgunj, Nepal
Mohan B.K.
General Physician, Ministry of Health, Oman
Samjhana Pokharel
Department of Gender Studies, Tribhuvan University, Nepal
Keywords:
COVID-19 stigma mental health Nepal

Abstract

Background: The COVID-19 pandemic has been associated with significant social and internalized stigma, particularly in low-resource settings. Yet, few studies have examined its psychological impact. This study aims to (1) find out the levels of COVID-19-related internalized stigma among confirmed COVID-19 cases and suspects in Nepal, (2) compare their scores and scores of anxiety and depressive symptoms between the two groups, and (3) find the associations of scores anxiety, and depressive symptoms with COVID-19-related internalized stigma in both groups.

Methods: It was a cross-sectional study conducted during the first wave (July–November 2020) in five health facilities in two provinces of Nepal, with 306 COVID-19 cases and 89 suspects. A semi-structured questionnaire, adapted Internalized Stigma of Mental Illness scale, and Hospital Anxiety and Depression Scale were administered. Descriptive and correlation analyses were used to compare the two groups.

Results: COVID-19 cases reported significantly more high COVID-19-related internalized stigma (25.2% cases, 3.4% suspects) (p<0.001) than the suspects. Cases reported significantly higher anxiety (28.1% vs. 6.7%) (p < 0.001) and depressive symptoms (38.9% vs. 12.4%) (*p* <0.001) than suspects. Among cases, anxiety and depressive symptoms correlated with COVID-19-related internalized stigma score (p=0.001; p<0.001) and four subdomains- alienation (p<0.001; p<0.001), stereotype endorsement (p<0.001; p<0.001), discrimination experience (p<0.001; p<0.001), social withdrawal (p<0.001; p<0.001). Whereas among the COVID-19 suspects, only social withdrawal (p=0.001) and stigma resistance (p<0.05) correlated with anxiety symptoms and there were no correlations with depressive symptoms.

Conclusion: The findings highlight the disproportionate psychological burden on COVID-19 cases, driven by internalized stigma related to the illness. Targeted mental health interventions are needed to mitigate the impact of stigma with attention to differences between cases and suspects.

Issue Cover
Published 2025-12-03